These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...

Cambridge, Massachusetts – home to Harvard and MIT – was the primary source of Chinese researchers who chose to head home.

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCERUNDER A LICENSING AGREEMENT, LINDIS HAS GRANTED PHARMANOVIA THE ...

Representative Jake Auchincloss discusses how the Democratic Party can offer meaningful alternatives to voters.

The NIH projected the cut will save it $4 billion during the current federal fiscal year, which ends September 30. That’s nearly half of the $9 billion that the NIH said it set aside for overhead ...

Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two consecutive days, ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

In an interview with the Globe, Kate Walsh, the state secretary of health and human services, discussed how President Trump’s ...

immunology specialist Zenas BioPharma has filed an initial public offering in the US seeking to add another $100 million to the pot. The five-year-old Waltham, Massachusetts-based company is ...

“We are delighted to welcome Don to our executive team,” said Greg Kunst, Aurion’s CEO. “Don’s track record of strategic and ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...